Julie A Chowen Selected Research

Chemokine CX3CL1

1/2021	A combination of circulating chemokines as biomarkers of obesity-induced insulin resistance at puberty.
7/2015	Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co-morbidity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julie A Chowen Research Topics

Disease

16	Body Weight (Weight, Body) 02/2022 - 04/2010
14	Obesity 01/2021 - 08/2010
10	Weight Gain 01/2018 - 04/2010
8	Gliosis 05/2022 - 08/2010
7	Inflammation (Inflammations) 05/2022 - 03/2012
6	Overnutrition 01/2019 - 05/2011
4	Malnutrition (Nutritional Deficiencies) 05/2022 - 09/2002
4	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2021 - 01/2011
4	Insulin Resistance 01/2021 - 03/2012
3	Hyperinsulinism (Hyperinsulinemia) 12/2019 - 01/2016
3	Mental Disorders (Mental Disorder) 01/2016 - 01/2015
2	Weight Loss (Weight Reduction) 01/2021 - 05/2010
2	Pediatric Obesity 01/2020 - 01/2013
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 12/2015
2	Cocaine-Related Disorders (Cocaine Addiction) 07/2015 - 01/2015
2	Type 2 Diabetes Mellitus (MODY) 07/2015 - 03/2012
2	Substance-Related Disorders (Drug Abuse) 01/2015 - 04/2009
2	Hyperglycemia 05/2010 - 05/2004
2	Diabetes Mellitus 11/2006 - 10/2006
1	Disease Progression 09/2021
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 09/2021
1	Bone Resorption 04/2021
1	Amyloid Plaque 01/2021
1	Brain Injuries (Brain Injury) 01/2021
1	Fatty Liver 01/2020
1	Dyslipidemias (Dyslipidemia) 01/2020
1	Glucose Intolerance 12/2019
1	Overweight 01/2018
1	Cognitive Dysfunction 01/2018
1	Alcoholism (Alcohol Abuse) 01/2016
1	Microcephaly 01/2016
1	Hypertriglyceridemia 01/2016

Drug/Important Bio-Agent (IBA)

21	LeptinIBA 02/2022 - 11/2010
12	Insulin (Novolin)FDA Link 11/2021 - 05/2004
9	Messenger RNA (mRNA)IBA 02/2022 - 09/2002
8	Proteins (Proteins, Gene)FDA Link 09/2021 - 05/2011
8	Hormones (Hormone)IBA 01/2021 - 09/2002
7	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 02/2022 - 08/2010
7	Insulin-Like Growth Factor I (IGF-1)IBA 04/2021 - 09/2002
7	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 05/2004
6	CytokinesIBA 01/2021 - 12/2014
5	Fatty Acids (Saturated Fatty Acids)IBA 05/2022 - 01/2015
5	SteroidsIBA 01/2020 - 09/2002
5	NeuropeptidesIBA 01/2018 - 11/2010
5	GhrelinIBA 03/2017 - 05/2004
4	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2016
4	Estradiol (Delestrogen)FDA LinkGeneric 01/2020 - 01/2016
3	Leptin ReceptorsIBA 09/2021 - 12/2016
3	Insulin-Like PeptidesIBA 01/2021 - 12/2015
3	ChemokinesIBA 01/2021 - 01/2015
3	Cocaine (Cocaine HCl)IBA 07/2015 - 04/2009
3	Sucrose (Saccharose)IBA 07/2013 - 06/2012
2	Interleukin-6 (Interleukin 6)IBA 05/2022 - 01/2015
2	VimentinIBA 05/2022 - 07/2013
2	CholesterolIBA 01/2021 - 01/2019
2	Chemokine CX3CL1IBA 01/2021 - 07/2015
2	Gonadal HormonesIBA 01/2021 - 04/2010
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2015
2	Uric Acid (Urate)IBA 01/2020 - 12/2019
2	AdipokinesIBA 01/2020 - 01/2013
2	AdiponectinIBA 01/2020 - 01/2016
2	LipidsIBA 10/2018 - 12/2014
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2018 - 12/2015
2	Estrogens (Estrogen)FDA Link 01/2018 - 01/2017
2	Insulin-Like Growth Factor Binding Protein 3IBA 01/2016 - 09/2002
2	Neuropeptide YIBA 07/2015 - 04/2015
2	Glutamic Acid (Glutamate)FDA Link 07/2013 - 11/2012
2	Growth Hormone (Somatotropin)IBA 01/2011 - 05/2010
2	Streptozocin (Streptozotocin)FDA Link 05/2010 - 11/2006
1	CannabinoidsIBA 05/2022
1	EndocannabinoidsIBA 05/2022
1	Monounsaturated Fatty AcidsIBA 05/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2022
1	Complement System Proteins (Complement)IBA 01/2021
1	Platelet-Derived Growth FactorIBA 01/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Becaplermin (PDGF-BB)FDA Link 01/2021
1	Amyloid beta-PeptidesIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	NucleotidesIBA 01/2020
1	Nonesterified Fatty Acids (NEFA)IBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	Palmitic Acid (Hexadecanoic Acid)IBA 01/2018
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 01/2018
1	Trp(8)-Cys(14)- somatostatinIBA 01/2018
1	beta Subunit Luteinizing HormoneIBA 01/2018
1	CarbohydratesIBA 01/2018
1	Blood Proteins (Serum Proteins)IBA 01/2016
1	AcidsIBA 01/2016
1	AndrogensIBA 01/2016
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2016
1	Testosterone (Sustanon)FDA Link 01/2016
1	Insulin-Like Growth Factor Binding ProteinsIBA 01/2016
1	Metalloproteases (Metalloproteinases)IBA 01/2016
1	Interleukin-1beta (Interleukin 1 beta)IBA 07/2015
1	Peptides (Polypeptides)IBA 07/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2015

Therapy/Procedure

2	Therapeutics 01/2015 - 05/2004